These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12105385)

  • 1. Combination ACEI and ARB therapy: additional benefit in renoprotection?
    Taal MW; Brenner BM
    Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):377-81. PubMed ID: 12105385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).
    Luno J; Praga M; de Vinuesa SG
    Curr Pharm Des; 2005; 11(10):1291-300. PubMed ID: 15853685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
    Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?
    Hilgers KF; Dötsch J; Rascher W; Mann JF
    Pediatr Nephrol; 2004 Sep; 19(9):956-61. PubMed ID: 15278690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
    Ferrari P; Marti HP; Pfister M; Frey FJ
    J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.
    Taal MW; Brenner BM
    Kidney Int; 2000 May; 57(5):1803-17. PubMed ID: 10792600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a place for combining angiotensin-converting enzyme inhibitors and angiotensin-receptor antagonists in the treatment of hypertension, renal disease or congestive heart failure?
    Taylor AA
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):643-8. PubMed ID: 11496059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors.
    Litwin M; Grenda R; Sladowska J; Antoniewicz J
    Pediatr Nephrol; 2006 Nov; 21(11):1716-22. PubMed ID: 16909244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists and treatment of hypertension and renal disease.
    Perico N; Remuzzi G
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):571-8. PubMed ID: 9818206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.
    Mackenzie HS; Ziai F; Omer SA; Nadim MK; Taal MW
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S283-6. PubMed ID: 10201884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.
    Homma K; Hayashi K; Kanda T; Yoshioka K; Takamatsu I; Tatematsu S; Kumagai H; Wakino S; Saruta T
    J Hum Hypertens; 2004 Dec; 18(12):879-84. PubMed ID: 15295613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y; Ohta K; Shimizu M; Nakai A; Kasahara Y; Yachie A; Koizumi S
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
    Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
    Wolf G; Ritz E
    Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL; Kalus JS; Coleman CI; Manierski C; Yee J
    Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis.
    Jiang YM; Song TR; Qiu Y; Liu JP; Wang XD; Huang ZL; Lin T
    Kaohsiung J Med Sci; 2018 Jan; 34(1):1-13. PubMed ID: 29310811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.
    Song JH; Cha SH; Hong SB; Kim DH
    J Hypertens Suppl; 2006 Mar; 24(1):S101-6. PubMed ID: 16601562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.